In this study, we show that NF-κB is the most highly activated transcription factor among those tested via in silico activated transcription factor analysis, and is responsible for differential gene expression in BCR-ABL-independent TKI-resistant CML cells. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.